Editorial: Altered expression of proteins in cancer: function and potential therapeutic targets, volume II

João Pessoa; Maria Teresa Valenti; Nadège Bellance; Paula Chiarella; Tamrat Abebe; Lorenzo Gerratana; Carlos Pérez-Plasencia; Julia Kzhyshkowska

doi:10.3389/fonc.2023.1242855

Editorial: Altered expression of proteins in cancer: function and potential therapeutic targets, volume II

Front Oncol. 2023 Jul 18:13:1242855. doi: 10.3389/fonc.2023.1242855. eCollection 2023.

Authors

João Pessoa^{1

2}, Maria Teresa Valenti³, Nadège Bellance⁴, Paula Chiarella⁵, Tamrat Abebe⁶, Lorenzo Gerratana⁷, Carlos Pérez-Plasencia^{8

9}, Julia Kzhyshkowska^{10

11

12

13}

Affiliations

¹ CNC - Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal.
² CIBB - Center for Innovative Biomedicine and Biotechnology, University of Coimbra, Coimbra, Portugal.
³ Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.
⁴ INSERM U1211, Rare Diseases: Genetic and Metabolism, University of Bordeaux, Bordeaux, France.
⁵ Department of Experimental Oncology, Instituto de Medicina Experimental, Academia Nacional de Medicina de Buenos Aires, Ciudad Autónima de Buenos Aires, Argentina.
⁶ Department of Microbiology, Immunology and Parasitology, School of Medicine, Addis Ababa University, Addis Ababa, Ethiopia.
⁷ Department of Medical Oncology, CRO Aviano, National Cancer Institute, IRCCS, Aviano, Italy.
⁸ Laboratorio de Genómica, Instituto Nacional de Cancerología, Tlalpan, Mexico.
⁹ Laboratorio de Genómica Funcional, Unidad de Biomedicina, FES-IZTACALA, Universidad Nacional Autónoma de México, Tlalnepantla, Mexico.
¹⁰ Institute of Transfusion Medicine and Immunology, Mannheim Institute for Innate Immunosciences (MI3), Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
¹¹ German Red Cross Blood Service Baden-Württemberg - Hessen, Mannheim, Germany.
¹² Laboratory for Translational Cellular and Molecular Biomedicine, Tomsk State University, Tomsk, Russia.
¹³ Laboratory for Gene Technology, Siberian State Medical University, Tomsk, Russia.

No abstract available

Keywords: cancer; down-regulation; protein expression levels; therapeutic target; up-regulation.

Publication types

Editorial

Grants and funding

This work was financed by the European Regional Development Fund (ERDF), through the COMPETE 2020 – Operational Programme for Competitiveness and Internationalization and Portuguese national funds via FCT – Fundação para a Ciência e a Tecnologia, under the projects UIDB/04539/2020, UIDP/04539/2020, and LA/P/0058/2020 (to JP); by Fondi Universitari di Ricerca (FUR; to MV); by Programa de financiamiento para la Investigación, UNAM, PAPIIT-IN231420, México, under the project UNAM-DGAPA: IN231420 (to CP-P); and by the state contract of the Ministry of Science and Higher Education of the Russian Federation “Genetic and epigenetic editing of tumor cells and microenvironment in order to block metastasis” (075-15-2021-1073) and by the Tomsk State University Development Programme (Priority 20-30; to JK).